Search - tctmd.com

Displaying 1 - 20 of 63

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2017

How Me The Data: Key Clinical Trials of 2017

Presenter: Curtiss T. Stinis

November 09, 2017

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

Presentation TCT 2017

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Rasha Al-Lamee

November 02, 2017

Presentation TCT 2017

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

Presenter: Saibal Kar

November 02, 2017

Presentation TCT 2017

RESOLVE/SAVORY: Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

Presenter: Deepak L. Bhatt, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

RESOLVE/SAVORY: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Presenter: Sahil A. Parikh, Thomas Zeller, Jihad A. Mustapha

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

Presenter: Gary M. Ansel, Sahil A. Parikh, Andrew J. Klein

November 01, 2017

Presentation TCT 2017

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

Presenter: Joachim Schofer

October 31, 2017

Presentation TCT 2017

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Samir R. Kapadia

October 31, 2017

Presentation TCT 2017

Current State of Thoracic Branch Devices and Ongoing Clinical Trials

Presenter: Brian G. DeRubertis, Peter A. Schneider, Hiroo Takayama

October 31, 2017

Presentation TCT 2017

TAP vs Culotte Stenting Beyond The Clinical Trials: A Different View

Presenter: Cihangir Kaymaz, Jeroen Vos, Armando Perez de Prado

October 31, 2017

Presentation TCT 2017

Representation of Women and Minorities in European Trials

Presenter: David P. Faxon, Cindy L. Grines, Angeles Alonso Garcia

October 31, 2017

Presentation TCT 2017

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Roxana Mehran

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Diversity in Clinical Trials

Presenter: David P. Faxon, Cindy L. Grines, Christopher J Popma

October 31, 2017

Presentation TCT 2017

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Presenter: Howard C. Herrmann, Michael J. Mack

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Short DAPT IDE Trials

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Advertisement

How Me The Data: Key Clinical Trials of 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

RESOLVE/SAVORY: Critique and Unanswered Questions

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

RESOLVE/SAVORY: Topline Findings and Practice Implications

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

The Most Important Clinical Trials of the Past Decade in Vascular Intervention

TRIGUARD Design Features and Clinical Findings From EU Clinical Trials

SENTINEL Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Current State of Thoracic Branch Devices and Ongoing Clinical Trials

TAP vs Culotte Stenting Beyond The Clinical Trials: A Different View

Representation of Women and Minorities in European Trials

Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials

FDA Perspectives on Diversity in Clinical Trials

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

FDA Perspectives on Short DAPT IDE Trials

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content